Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Commission Predicts 43 Notified Bodies Under MDR And 12 Under IVDR By End November

Executive Summary

Altered compliance timelines under the EU’s Medical Device and IVD Regulations give the sectors more time. But urgency remains for manufacturers to hire notified bodies to assess their products. Expanded capacity bandwidth is promised soon.

You may also be interested in...



Latest Notified Body Designated Under the EU’s MDR Is A Software Specialist

In the EU, notified bodies are usually designated for a wide spectrum of testing of different types of medical devices under the Medical Device Regulation. The latest organization to be named, however, is a specialist.

Notified Body Designations Under The MDR Hit The 40 Mark With New Turkish Designation

Turkey may not be part of the EU, but its customs agreement with the bloc enables it to designate notified bodies under the EU’s Medical Device and IVD Regulations. The first such designation has just been announced.

Second Finnish Notified Body To Be Designated Within Two Months Under The EU IVDR

With a population of just over 5.5 million, Finland represents just 1.2% of the EU’s total population. Its testing capacity under the EU's IVD Regulation, in terms of numbers of notified bodies, now appears proportionately bigger than that of any other country.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT148351

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel